← Back to Search

Nest Software for Cancer Syndromes

N/A

Waitlist Available

Led By Jennifer W Mack, MD

Research Sponsored by Nest Genomics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Not in active cancer therapy at the time of approach

English-speaking and -reading

Must not have

Age <18 or >39 years

Non-English speaking and reading

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, within 7 days of visit

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test if a software platform called Nest can help young adults at genetic risk for cancer with their cancer screening. Researchers want to see if Nest users are more informed about their cancer risks and

Who is the study for?

This trial is for young adults at genetic risk for cancer. Participants must be willing to use the Nest software, attend genetic counseling or follow-up visits, take surveys, and complete recommended screenings and care. Specific inclusion or exclusion criteria are not provided.

What is being tested?

The trial tests if the Nest software platform can improve knowledge about cancer risks, reduce psychological distress, encourage sharing of cancer information with family/doctors, and ensure up-to-date care plans compared to non-users.

What are the potential side effects?

Since this trial involves a software platform rather than medication or medical procedures, traditional physical side effects are not expected. However, there may be emotional or psychological impacts from learning about personal cancer risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am not currently undergoing cancer treatment.

Select...

I can speak and read English.

Select...

I am between 18 and 39 years old.

Select...

I have a genetic mutation linked to cancer, confirmed by a doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am either younger than 18 or older than 39 years old.

Select...

I do not speak or read English.

Select...

I have not had genetic testing for cancer or my test did not find any high-risk gene changes.

Select...

I am currently receiving treatment for my cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, within 7 days of visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, within 7 days of visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, within 7 days of visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of Intervention Measure (AIM)

Distress Thermometer (DT)

Gist Comprehension of Genetic Cancer Risk

+2 more

Secondary study objectives

Uncertainty of Illness Measures

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ArmExperimental Treatment1 Intervention

Patients in the intervention arm will complete a genetic counseling or follow-up visit with a clinician using Nest Clinical Decision Support and a post visit-survey. Intervention arm patients will be given access to the Nest Patient Navigator.

Group II: Control ArmActive Control1 Intervention

Patients in the control arm will complete a standard genetic counseling or follow-up visit and a post-visit survey.

0 / 8Eligibility criteria met